Table 5.
Association of biomarker levels with the extent of fibrosis.
| Linear Regression | Univariate | Multivariate |
|---|---|---|
| Variables | r | rpartial |
| sCr | 0.62 **** | 0.29 ** |
| PU | 0.14 | NR |
| S-C3M | 0.13 | NR |
| U-C3M/Cr | −0.51 **** | −0.24 ** |
| S-C3C | 0.24 ** | NR |
| U-C3C/Cr | 0.23 * | NR |
| S-PRO-C3 | 0.30 *** | NR |
| U-PRO-C3/Cr | 0.18 | NR |
| Hypertension, yes | 0.17 | NR |
| Diabetes, yes | −0.15 | NR |
Univariate and multivariate (with backwards elimination) linear regression analysis. Variables and outcome (level of fibrosis (%)) used for the regression analysis were log10 transformed for the linear regression analysis. Statistical significance; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. NR, not retained in the model; PU, proteinuria; sCr, serum creatinine.